The relationship between the chemical structure and hypotensive activity of a series of new benzimidazole and quinoxaline derivatives.
D000284:Administration, Oral; D000818:Animals; D000959:Antihypertensive Agents; D001562:Benzimidazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D006973:Hypertension / Q000139:chemically induced / Q000188:drug therapy*; D002546:Ischemic Attack, Transient / Q000139:chemically induced; D008970:Molecular Weight; D010276:Parasympatholytics / Q000494:pharmacology / Q000627:therapeutic use; D010909:Pituitary Hormones, Posterior; D011189:Potassium Chloride; D011810:Quinoxalines / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012119:Respiration / Q000187:drug effects
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D010276:Parasympatholytics; D010909:Pituitary Hormones, Posterior; D011810:Quinoxalines; D011189:Potassium Chloride
Zavisimost' mezhdu khimicheskimstroeniem i gipotenzivnoĭ aktivnost'ie v riadr novykh proizvodnykh benzimikazolai khinoksaline.